Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

LEMAITRE VASCULAR, INC.

(LMAT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

LeMaitre Vascular : Will Announce Third Quarter 2021 Earnings Results on October 28, 2021

10/14/2021 | 04:11pm EST

BURLINGTON, Mass., Oct. 14, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2021 financial results on Thursday, October 28, 2021, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook.

Access to the live call is available by dialing 844-239-5284 (+1-512-961-6497 for international callers), passcode 8308248. The call can also be accessed live or via replay through a webcast at www.lemaitre.com/investor.

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.


All news about LEMAITRE VASCULAR, INC.
11/18LEMAITRE VASCULAR, INC. : Ex-dividend day for
FA
11/04INSIDER SELL : Lemaitre Vascular
MT
11/04LEMAITRE VASCULAR INC Management's Discussion and Analysis of Financial Condition and ..
AQ
11/02LeMaitre to Participate at Upcoming Investor Conferences
GL
10/29Barrington Adjusts Price Target on LeMaitre Vascular to $62 From $64, Maintains Outperf..
MT
10/29LeMaitre Vascular Q3 Earnings Slip as Revenue Rises; Lowers Midpoint Full-Year Guidance..
MT
10/28LEMAITRE : Q3 Earnings Snapshot
AQ
10/28LeMaitre Q3 2021 Financial Results - Form 8-K
PU
10/28LeMaitre Vascular, Inc. Reports Earnings Results for the Third Quarter and Nine Months ..
CI
10/28Earnings Flash (LMAT) LEMAITRE VASCULAR Posts Q3 Revenue $38.4M, vs. Street Est of $39M
MT
More news
Analyst Recommendations on LEMAITRE VASCULAR, INC.
More recommendations
Financials (USD)
Sales 2021 155 M - -
Net income 2021 27,6 M - -
Net Debt 2021 - - -
P/E ratio 2021 36,9x
Yield 2021 0,68%
Capitalization 1 035 M 1 035 M -
Capi. / Sales 2021 6,69x
Capi. / Sales 2022 6,20x
Nbr of Employees 395
Free-Float 82,2%
Chart LEMAITRE VASCULAR, INC.
Duration : Period :
LeMaitre Vascular, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LEMAITRE VASCULAR, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 47,40 $
Average target price 65,86 $
Spread / Average Target 38,9%
EPS Revisions
Managers and Directors
George W. LeMaitre Chairman & Chief Executive Officer
David B. Roberts President & Director
Joseph P. Pellegrino CFO, Secretary, Treasurer & Director
Jonathan W. Ngau Vice President-Information Technology
Ryan H. Connelly Vice President-Research & Development
Sector and Competitors